Latest News & Features
Europe
Spain’s new patent law came into force on April 1, and it contains a few measures which will affect pharmaceutical companies, says Dámaso Gallardo of Clarke Modet & Co. 28 June 2017
Biotechnology
The formal requirements for priority have become a hot topic at the European Patent Office, driven by their importance in high-profile oppositions to the Broad Institute’s CRISPR/Cas9 patents, as Catherine Coombes of HGF explains. 28 June 2017
Americas
American Chemical Society, a scientific society, has taken on nearly 100 alleged counterfeiters accused of creating two pirate sites and sharing the society’s scientific articles. 27 June 2017
Americas
The Food and Drug Administration has announced its intention to target the barriers to generic drug competition. 26 June 2017
Americas
The governor of Massachusetts has revealed a legislative proposal aimed at providing up to $500 million over the next five years in the life sciences sector. 26 June 2017
Americas
Biopharmaceutical company Omeros has filed a complaint against Sandoz for allegedly infringing its patent covering Omidria. 23 June 2017
Americas
Earlier this month, the US Supreme Court handed down its decision in the biosimilars battle between Amgen and Sandoz, centring on the Biologics Price Competition and Innovation Act. 23 June 2017
Americas
GSK has won a patent case against Teva in which the company will receive $235 million in damages. 22 June 2017
Americas
“There’s one stick with this carrot—the whistleblower protection law,” explained Anne Elise Li, IP counsel at Crowell & Moring, in reference to the Defend Trade Secrets Act. 22 June 2017
Americas
The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent sub-ject matter eligibility. 22 June 2017